Advanced Filters
noise

Tinnitus Clinical Trials

A listing of Tinnitus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 133 clinical trials
A Aurélien GUFFROY, MD

Familial Systemic Scleroderma

Studying familial forms of systemic scleroderma offers several advantages: To better understand the pathophysiology of a complex autoimmune disease based on "extreme" cases (familial forms); To identify potential molecular markers predictive of disease progression; To identify potential pathophysiological targets for developing new therapies, particularly relevant in severe and refractory forms …

18 years of age All Phase N/A
R Rong Xiao, MD

Subcutaneous Semaglutide in Systemic Scleroderma

This trial will study the safety and efficacy of subcutaneous semaglutide for the treatment of Systemic Sclerosis

18 - 65 years of age All Phase 1

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Scleroderma (SSc) is an autoimmune disease characterized by fibrosis (or collagen deposition) of the skin and internal organs. The extent of skin fibrosis is an important predictor of internal organ complications and increased mortality. Currently a very imprecise, subjective method that varies amongst different doctors for the same patient is …

18 years of age All Phase N/A
D Dezeray Cephas Dutton

Sildenafil for Early Pulmonary Vascular Disease in Scleroderma

This is a Phase II randomized, double-blind, placebo-controlled trial of sildenafil in men and women with Scleroderma with mildly elevated pulmonary pressures (SSc-MEP) to determine whether sildenafil may be an effective treatment for SSc-MEP.

18 years of age All Phase 2
T Toby Maher

Platform Clinical Study for Conquering Scleroderma

The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.

18 years of age All Phase 2
E Elizabeth Haro, MPH

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all …

18 - 70 years of age All Phase N/A
S Songul B Yentur

Connective Tissue Massage in Scleroderma

The only study in the literature that examined connective tissue massage in patients with scleroderma is by Bongi et al. In this study, connective tissue massage and Mc Mennell joint manipulation technique were applied to the experimental group in addition to the home exercise program. The control group was offered …

18 - 65 years of age All Phase N/A
B Bernard BONNOTTE

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Scleroderma is a complex connective tissue disease involving three interconnected pathophysiological axes: vascular hyperactivity and remodelling, immune system dysfunction and over-activation of fibroblasts at the origin of the fibrosis process in the skin and organs. Given that this pathology occurs preferentially in mature subjects, it is possible to suggest a …

18 years of age All Phase N/A
J Jing Xue

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

This study is a prospective, open-label, randomized, controlled, multi-center clinical trial. The aim of this study is to investigate the efficacy and safety of Telitacicept in adults with early diffuse cutaneous systemic sclerosis (dcSSc), with Mycophenolate Mofetil (MMF) administered as a background treatment.

18 - 70 years of age All Phase 2
F Fahad Hossain, MBBS, MD

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Systemic sclerosis (SSc) is a systemic autoimmune disease. It causes progressive skin tightening, pulmonary fibrosis, organ damage and many other physical dysfunctions. It is divided into two types, limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dcSSCc). Skin involvement in systemic sclerosis is assessed by modified Rodnan skin …

18 years of age All Phase 3

Simplify language using AI